arrow_back Back Filing freshness 10-Q Q1 FY2026 SEC EDGAR

OptimizeRx Corp

OPRX
$7.07 ▲ +0.33 (+4.90%) at close
Industrials ·Services-Business Services, NEC ·USServices-Business Services, NEC
64 Visible periods
32 Metrics
Peer-ranked Benchmarks
Price Chart
64
Health
Fair
Neutral
auto_awesome

Analytical Summary

OptimizeRx Corp shows mixed fundamentals. Consider comparing against peers in the Industrials sector before making investment decisions.

Market Cap $132.6M
Dividend Yield
Revenue Growth -9.5%
Op. Margin 2.0%
ROIC 0.2%
FCF / Share $-0.03
Trailing P/E
Price / Book 1.0x
FCF Yield
Debt / Equity 0.18
info Valuation on last close. End-of-day price, Aug 7, 2026.

64-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$19.84M
↓ -9.5%
Net Income Profit after all expenses
$-495.00K
↑ +77.5%
Operating Margin Operating profit as % of sales
2.0%
↓ -92.5% 58th
FCF / Share Free cash flow per share
$-0.03
↓ -115.1%
Long-Term Debt Long-term obligations
$23.60M
↓ -10.2%

Health Breakdown

Profitability
61
Returns
51
Financial Health
68
Cash Quality
93

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 16 years · 64 quarters